Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-20

FDA Approved: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC — Supplemental Application (Florida Pharmaceutical Products, LLC)

View source ↗

Summary

FDA approved a supplemental application for dorzolamide hydrochloride ophthalmic solution filed by Florida Pharmaceutical Products, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide hydrochloride ophthalmic solution (Dorzolamide hydrochloride)

Snippet

SUPPL AP for DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC (DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC)